Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer

Journal of Physiology and Pharmacology

Volumn 60, Issue SUPPL.6, 2009, Pages 55-60

  Strus, M ^a   Janczyk, A ^b   Gonet Surowka, A ^a   Brzychczy Wloch, M ^a   Stochel, G ^b   Kochan, P ^a   Heczko, Piotr B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Apoptosis; Cancer; Epithelial cells; Gut; Hydrogen peroxide; Inflammatory bowel disease; Reactive oxygen species

Indexed keywords

HYDROGEN PEROXIDE; PROBIOTIC AGENT;

APOPTOSIS; ARTICLE; CELL STRAIN HT29; COLON TUMOR; DRUG EFFECT; ENTERITIS; HUMAN; LACTOBACILLUS DELBRUECKII; METABOLISM; MICROBIOLOGY; NECROSIS; PATHOLOGY; STOMACH MUCOSA;

APOPTOSIS; COLONIC NEOPLASMS; GASTRIC MUCOSA; HT29 CELLS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS DELBRUECKII; NECROSIS; PROBIOTICS;

EID: 77954501379     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clark RA, Nauseef WM. Isolation and functional analysis of neutrophils. Curr Protoc Immunol 2001; 7: 7-23.
2. Becker S, Soukup JM, Gallagher JE. Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages. Toxicol In Vitro 2002; 16: 209-218.
3. Ocana VS, Pesce de Ruiz Holgado AA, Nader-Macias ME. Selection of vaginal H2O2-generating Lactobacillus species for probiotic use. Curr Microbiol 1999; 38: 279-284.
4. Strus M, Gosiewski T, Kochan P, Heczko PB. A role of hydrogen peroxide producing commensal bacteria present in colon of children with IBD in perpetuation of the inflammatory process. J Physiol Pharmacol 2009; 60(Suppl. 6): 49-54.
5. Zabielski R, Godlewski MM, Guilloteau P. Control of development of gastrointestinal system in neonates. J Physiol Pharmacol 2008; 59(Suppl 1): 35-54.
6. Gibson PR. Apoptosis or necrosis-colonic epithelial cell survival. Novartis Found Symp 2004; 263: 133-150.
7. Henle ES, Linn S. Formation, prevention and repair of DNA damage by iron/hydrogen peroxide. J Biol Chem 1997; 272: 19095-19098.
8. Spalek T, Kruczala K, Sojka Z, Schlick S. Deducing 1D concentration profiles from EPR imaging: a new approach based on the concept of virtual components and optimization with the genetic algorithm. J Magn Reson 2007; 189: 139-150.
9. Buettner GR, Moseley PL. EPR spin trapping of free radicals produced by bleomycin and ascorbate. Free Radic Res Commun 1993; 19: S89-S93.
10. Zhao BL, Duan SJ, Xin WJ. Lymphocytes can produce respiratory burst and oxygen radicals as polymorphonuclear leukocytes. Cell Biophys 1990; 17: 205-211.
11. Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89: 587-595.
12. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43: 3380-3389.
13. Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 11-18.
14. Pacelli R, Wink DA, Cook JA, et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 1995; 182: 1469-1479.
15. Weersma RK, van Dullemen HM, van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G. Review article: Inflammatory bowel disease and genetics. Aliment Pharmacol Ther 2007; 26: 57-65.
16. Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008; 57: 463-467.
17. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 429-438.
18. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003; 201: 28-36.
19. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52: 2015-2021.
20. Reth M. Oligomeric antigen receptors: a new view on signaling for the selection of lymphocytes. Trends Immunol 2001; 22: 356-360.
21. Schreck R, Baeuerle PA. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol 1994; 234: 151-163.
22. Cao WG, Morin M, Metz C, Maheux R, Akoum A. Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB. Biol Reprod 2005; 73: 565-570.
23. Leung AM, Redlak MJ, Miller TA. Oxygen radical induced gastric mucosal cell death: apoptosis or necrosis? Dig Dis Sci 2008; 53: 2429-2435.
24. Denning TL, Takaishi H, Crowe SE, Boldogh I, Jevnikar A, Ernst PB. Oxidative stress induces the expression of Fas and Fas ligand and apoptosis in murine intestinal epithelial cells. Free Radic Biol Med 2002; 33: 1641-1650.
25. Kaczmarek M, Frydrychowicz M, Nowicka A, Kozlowska M, et al. Influence of pleural macrophages on proliferative activity and apoptosis regulating proteins of malignant cells. J Physiol Pharmacol 2008; 59(Suppl 6): 321-330.
26. Chiozzi V, Mazzini G, Oldani A, et al. Relationship between Vac A toxin and ammonia in Helicobacter pylori-induced apoptosis in human gastric epithelial cells. J Physiol Pharmacol 2009; 60(3): 23-30.
27. Rutkowski R, Pancewicz SA, Rutkowski K, Rutkowska J. Reactive oxygen and nitrogen species in inflammatory process. Pol Merkur Lek 2007; 23: 131-136.
28. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002; 23: 529-536.
29. Oldenburg B, van Berge Henegouwen GP, Rennick D, Van Asbeck BS, Koningsberger JC. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000; 30: 505-510.
30. Reifen R, Matas Z, Seidel L, Berkovitch Z, Bujanover Y. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 2000; 45: 394-397.
31. Uritski R, Barshack I, Bilski I, Ghebremeskel K, Reifen R. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr 2004; 134: 2251-2255.
32. Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005; 40: 1058-1065.
33. Millar AD, Rampton DS, Blake RD. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000; 14: 1163-1168.
34. Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci 2008; 53: 2524-2531.
35. Heczko PB, Strus M, Kochan P. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol 2006; 57: 5-12.
36. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006; 57: 23-33.